chr17-59210310-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018149.7(SMG8):c.259G>T(p.Asp87Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018149.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMG8 | NM_018149.7 | c.259G>T | p.Asp87Tyr | missense_variant | 1/4 | ENST00000300917.10 | NP_060619.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMG8 | ENST00000300917.10 | c.259G>T | p.Asp87Tyr | missense_variant | 1/4 | 1 | NM_018149.7 | ENSP00000300917.4 | ||
ENSG00000265303 | ENST00000577660.1 | c.136-4495G>T | intron_variant | 3 | ENSP00000464167.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248304Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134404
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1460822Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726692
GnomAD4 genome AF: 0.000184 AC: 28AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74342
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.259G>T (p.D87Y) alteration is located in exon 1 (coding exon 1) of the SMG8 gene. This alteration results from a G to T substitution at nucleotide position 259, causing the aspartic acid (D) at amino acid position 87 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at